Pirfenidone use to treat IPF was associated with fewer arrhythmic events and less diastolic dysfunction compared to patients who did not use pirfenidone during long-term follow-up. Additionally, obesity is associated with a higher incidence of arrhythmic events in patients with IPF.
Im et al. (Mon,) studied this question.